Evidence map›Paper›PMID 39518029›Full record

ArticleCancers2024

A New IL-6-Inducing Mechanism in Cancer with New Therapeutic Possibilities.

Leif Håkansson, Pontus Dunér, Erik Broströmer, Bengt Gustavsson, Yvonne Wettergren, Bijar Ghafouri, Annika Håkansson, Birgitta Clinchy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Leif HåkanssonDivision of Clinical Tumorimmunology, Department of Oncology, University Hospital of Linkoping, 581 85 Linkoping, Sweden.
Pontus DunérDepartment of Clinical Sciences Malmö, Lund University, 205 02 Malmö, Sweden.
Erik BroströmerStröm & Gulliksson AB, P.O. Box 793, 220 07 Lund, Sweden.
Bengt GustavssonDepartment of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.
Yvonne WettergrenDepartment of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.ORCID 0000-0001-8660-7169
Bijar GhafouriPain and Rehabilitation Center, Department of Health, Medicine and Caring Sciences, Linköping University, 581 85 Linköping, Sweden.ORCID 0000-0002-6396-5104
Annika HåkanssonDepartment of Oncology, Uppsala University Hospital, 751 85 Uppsala, Sweden.
Birgitta ClinchyDepartment of Clinical and Experimental Medicine, Division of Clinical Immunology, Linköping University Hospital, 581 85 Linköping, Sweden.

Funding

Funding for this study was provided by: the Swedish state under the LUA/ALF agreement (ALFGBG-966007) and the Swedish Cancer Society (CAN 22 2370), County Council of Östergöt-land and the Health Research Council in the South East of Sweden. Canimguide The Funding for this study was provided by: the Swedish state under the LUA/ALF agreement (ALFGBG-966007) and the Swedish Cancer Society (CAN 22 2370), County Council of Östergöt-land and the Health Research Council in the South East of Sweden. Canimguide The
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

albumin neo-structureautoantibodiescancerIL-6-inducing factorimmune complexesimmunoregulationinterleukin-6PBMCsprognosis

Identifiers

PMID39518029
PMCPMC11545478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.